Lead sponsor
Ferrer Internacional S.A.
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
1
Trials led
1
Ongoing
241
Total enrollment
44
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Trials by status
Active, not recruiting
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP)MoCA ≥23Ph 2Active, not recruiting241